Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Vigo – page 12

308 clinical trials in Vigo, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Vigo at a glance
308
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

308 trials in Vigo

Open in trial search

Neoplasm malignant

Not yet recruiting

Study on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Sutro Biopharma Inc.

Acute myocardial infarction+1

Not yet recruiting

Study on the Safety and Effectiveness of ApTOLL for Patients with ST Elevation Myocardial Infarction (STEMI)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Aptamer-4Ft
  • Sponsor:Aptatargets S.L.

Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Summit Therapeutics Inc.

Study on the Safety and Effectiveness of GFH925 and Cetuximab for Patients with Advanced Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Zhejiang Genfleet Therapeutics Co. Ltd.

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Colitis ulcerative

Not recruiting

Evaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Rheumatoid arthritis

Not recruiting

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Migraine

Not recruiting

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:IncobotulinumtoxinA
  • Sponsor:Merz Therapeutics GmbH

Migraine

Not recruiting

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:IncobotulinumtoxinA
  • Sponsor:Merz Therapeutics GmbH

Schizophrenia

Not recruiting

Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Evenamide
  • Sponsor:Newron Pharmaceuticals S.p.A.

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Vigo

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on various cancer treatments, including studies for gastric cancer, non-small cell lung cancer, and breast cancer. Research involves combination therapies and novel treatment approaches.

  • Advanced gastric and gastroesophageal cancer treatments
  • Targeted therapies for lung cancer
  • Triple-negative breast cancer interventions

Multiple studies evaluating immunotherapy combinations and chemotherapy protocols for improved patient outcomes.

02 Infectious Diseases

Comprehensive research programs examining treatments for HIV infections and influenza, including preventive measures and therapeutic interventions.

  • HIV pre-exposure prophylaxis studies
  • Influenza vaccine efficacy trials
  • Antiviral therapy evaluations

Focus on developing improved prevention strategies and treatment options for viral infections.

03 Cardiovascular Research

Studies investigating treatments for heart failure prevention and atrial fibrillation, with emphasis on innovative therapeutic approaches.

  • Heart failure risk reduction studies
  • Anticoagulation therapy research
  • Cardiovascular disease prevention

Evaluating new drug combinations and treatment strategies for improved cardiac outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.